Application 216848
- Type
- ANDA
- Sponsor
- LEPU PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 10MG BASE | No | No |
| 002 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 20MG BASE | No | No |
| 003 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 40MG BASE | No | No |
| 004 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 80MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216848-001 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2022-11-03 | ||
| A216848-002 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2022-11-03 | ||
| A216848-003 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2022-11-03 | ||
| A216848-004 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2022-11-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216848-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2022-11-03 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216848-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2022-11-03 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216848-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2022-11-03 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216848-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2022-11-03 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216848-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2022-11-03 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216848-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2022-11-03 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216848-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2022-11-03 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216848-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2022-11-03 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216848-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2022-11-03 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216848-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2022-11-03 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216848-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2022-11-03 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216848-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2022-11-03 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216848-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2022-11-03 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216848-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2022-11-03 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216848-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2022-11-03 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216848-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2022-11-03 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A216848-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2022-11-03 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | A216848-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2022-11-03 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | A216848-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2022-11-03 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | A216848-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2022-11-03 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A216848-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2022-11-03 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | A216848-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2022-11-03 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | A216848-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2022-11-03 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | A216848-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2022-11-03 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216848-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2022-11-03 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216848-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2022-11-03 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216848-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2022-11-03 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216848-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2022-11-03 | 3a93d1ddd44b… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216848-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2022-11-03 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216848-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2022-11-03 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216848-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2022-11-03 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216848-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2022-11-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-05-13 08:27 UTC | 2023-05 | A216848-001 | AB | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | A216848-002 | AB | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | A216848-003 | AB | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | A216848-004 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A216848-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A216848-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A216848-003 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A216848-004 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216848-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216848-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216848-003 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216848-004 | AB | 1 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| atorvastatin calcium | ATORVASTATIN CALCIUM | Lepu Pharmaceutical Technology Co., Ltd. | 173474b6-26b4-46f2-a12a-64753ae5e905 | 2025-10-29 | Warnings, Adverse reactions | 216848 ANDA216848 82137-016 82137-017 82137-019 82137-018 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 82137-016 | atorvastatin calcium | atorvastatin calcium | Lepu Pharmaceutical Technology Co., Ltd. | ANDA | Current |
| 82137-017 | atorvastatin calcium | atorvastatin calcium | Lepu Pharmaceutical Technology Co., Ltd. | ANDA | Current |
| 82137-018 | atorvastatin calcium | atorvastatin calcium | Lepu Pharmaceutical Technology Co., Ltd. | ANDA | Current |
| 82137-019 | atorvastatin calcium | atorvastatin calcium | Lepu Pharmaceutical Technology Co., Ltd. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 84046 | ORIG | 2025-11-04 |